BioWorld Asia

May 6, 2009

Report: Global Funding Crisis Endangering Biotech Model

LONDON - The global financial crisis is making the biotech business model unsustainable, says the consultancy Ernst and Young in its 23rd annual report on the industry. (BioWorld International) Read More

UK's Biotech Problems Bemoaned at Conference

Resequencing Study May Lead to Better Genetic Counseling

Vernalis Raises £22M Offering Hefty Discount

BioXell Shares Plunge on Elocalcitol Miss

Circ, Elan Partner on Pain Drug Formulation

Cerep and PerkinElmer Expand Assay Offering

Pharmaxis Hits the Mark in Phase III Cystic Fibrosis Trial

Other News To Note

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026